Moreover, our study revealed that MGMT suppression by a specific inhibitor or the siRNA technique reduced CDDP-mediated RAD51 expression in NPC cells, comparable to the positive correlation data between MGMT and RAD51 expression levels observed in a cohort of NPC patients (GSE102349). The gene discussed is RAD51; the disease is nasopharyngeal carcinoma.